| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
EVP, Chief Legal Officer, Sec | See Remarks
2 companies
Rhodes Jennifer J is a See Remarks at Elicio Therapeutics, Inc. with holdings across 2 companies. Recent SEC Form 4 filings include 0 buys and 3 sells.
Estimated insider holdings value: $554K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr 15, 2021 | ELTX Elicio Therapeutics, Inc. | See Remarks | Sell | 399 | $15.01 | $5,988.99 | -1.2% | -28.3% | -88.4% | |
| Mar 13, 2021 | ELTX Elicio Therapeutics, Inc. | See Remarks | Sell | 499 | $20.45 | $10,204.55 | -1.4% | -35.5% | -91.7% | |
| Feb 13, 2021 | ELTX Elicio Therapeutics, Inc. | See Remarks | Sell | 457 | $19.54 | $8,929.78 | -1.3% | - | - |